D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Lowe's Companies
LOW
|
+$638M |
| 2 |
NVIDIA
NVDA
|
+$461M |
| 3 |
EQT Corp
EQT
|
+$400M |
| 4 |
Citigroup
C
|
+$369M |
| 5 |
CELG
Celgene Corp
CELG
|
+$339M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$694M |
| 2 |
Dell
DELL
|
+$486M |
| 3 |
IBM
IBM
|
+$341M |
| 4 |
Amgen
AMGN
|
+$306M |
| 5 |
Johnson & Johnson
JNJ
|
+$264M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.05% |
| 2 | Healthcare | 10.49% |
| 3 | Consumer Discretionary | 10.21% |
| 4 | Financials | 8.38% |
| 5 | Industrials | 7.77% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2726
Elevance Health
ELV
$81.9B
| $635K | ﹤0.01% |
2,893
-30,596
| -91% | -$7.19M |
|
2727
CALL
Snap
SNAP
$7.32B
| $635K | ﹤0.01% |
+40,000
| New | +$649K |
|
2728
Descartes Systems
DSGX
$5.84B
| $634K | ﹤0.01% |
+22,200
| New | +$619K |
|
|
RTN
2729
CALL
DELISTED
Raytheon Company
RTN
| $626K | ﹤0.01% |
2,900
-1,800
| -38% | -$372K |
|
2730
SLR Investment Corp
SLRC
$706M
| $623K | ﹤0.01% |
30,685
-40,282
| -57% | -$829K |
|
2731
GATX Corp
GATX
$6.55B
| $621K | ﹤0.01% |
9,058
-74,741
| -89% | -$5.11M |
|
2732
Western Alliance Bancorporation
WAL
$9.07B
| $620K | ﹤0.01% |
+10,669
| New | +$632K |
|
|
AUTO
2733
DELISTED
AutoWeb, Inc. Common Stock
AUTO
| $619K | ﹤0.01% |
207,632
-44,608
| -18% | -$308K |
|
|
CVA
2734
DELISTED
Covanta Holding Corporation
CVA
| $618K | ﹤0.01% |
42,587
-52,102
| -55% | -$821K |
|
|
ICPT
2735
CALL
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
| $615K | ﹤0.01% |
+10,000
| New | +$603K |
|
2736
KeyCorp
KEY
$24.3B
| $614K | ﹤0.01% |
31,429
-212,386
| -87% | -$4.45M |
|
2737
PUT
Match Group
MTCH
$8.84B
| $613K | ﹤0.01% |
+13,800
| New | +$534K |
|
|
RRD
2738
DELISTED
RR Donnelley & Sons Co.
RRD
| $613K | ﹤0.01% |
70,223
-554,254
| -89% | -$4.59M |
|
2739
Pacira BioSciences
PCRX
$1.02B
| $611K | ﹤0.01% |
19,616
-2,284
| -10% | -$81.3K |
|
|
HDP
2740
CALL
DELISTED
Hortonworks, Inc.
HDP
| $611K | ﹤0.01% |
30,000
| – | – |
|
2741
Waterstone Financial
WSBF
$362M
| $610K | ﹤0.01% |
35,262
-6,306
| -15% | -$109K |
|
2742
CorVel
CRVL
$3.05B
| $609K | ﹤0.01% |
36,165
+855
| +2% | +$14.5K |
|
2743
Eagle Materials
EXP
$6.6B
| $606K | ﹤0.01% |
+5,883
| New | +$634K |
|
2744
Sabra Healthcare REIT
SBRA
$5.64B
| $605K | ﹤0.01% |
34,287
-418,902
| -92% | -$7.38M |
|
2745
Hercules Capital
HTGC
$2.94B
| $600K | ﹤0.01% |
49,614
-118,938
| -71% | -$1.49M |
|
|
VIA
2746
DELISTED
Via Renewables, Inc. Class A Common Stock
VIA
| $599K | ﹤0.01% |
+10,111
| New | +$539K |
|
|
JOBS
2747
DELISTED
51job Inc
JOBS
| $599K | ﹤0.01% |
6,962
-280
| -4% | -$20.2K |
|
2748
Sarepta Therapeutics
SRPT
$1.66B
| $598K | ﹤0.01% |
8,077
-166,998
| -95% | -$11.1M |
|
|
FSP
2749
Franklin Street Properties
FSP
$44.8M
| $597K | ﹤0.01% |
70,998
-124,360
| -64% | -$1.15M |
|
|
KYO
2750
DELISTED
Kyocera Adr
KYO
| $597K | ﹤0.01% |
10,525
+4,472
| +74% | +$275K |
|
Similar funds
D.E. Shaw & Co's Q1 2018 Portfolio in Review
As of Q1 2018, D.E. Shaw & Co held 3,998 positions worth $73.5B, up 1.2% from $72.6B the previous quarter. Its ten largest holdings account for 9.5% of the portfolio.
D.E. Shaw & Co's Q1 2018 filing shows 451 new, 1,293 increased, 1,502 reduced and 554 closed positions. Its largest new stake was GCI Liberty, Inc. Class A Common Stock (DE): 2,434,094 shares worth $129M. The largest sale was Meta Platforms (Facebook), an estimated $694M.
By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 13% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- D.E. Shaw & Co's largest Q1 2018 buy was GCI Liberty, Inc. Class A Common Stock (DE): 2,434,094 shares worth $129M.
- D.E. Shaw & Co added most to Lowe's Companies in Q1 2018, an estimated $638M increase.
- D.E. Shaw & Co's biggest Q1 2018 reduction was Meta Platforms (Facebook), cutting an estimated $694M.
- D.E. Shaw & Co fully exited Liberty Interactive Corporation Series A Liberty Ventures in Q1 2018, selling an estimated $141M.
- D.E. Shaw & Co's ten largest holdings make up 9.5% of its $73.5B portfolio in Q1 2018.
- D.E. Shaw & Co opened 451 new positions and closed 554 in Q1 2018.
- D.E. Shaw & Co's portfolio value rose 1.2% quarter-over-quarter to $73.5B.
Based on D.E. Shaw & Co's 13F filing for Q1 2018, filed 15 May 2018.